Historical Stock Price
ETFs Holding CLDN »    CLDN Split History »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
03/16/2016 $1.12 $1.13 $1.10 $1.13 40.60K
03/17/2016 $1.12 $1.14 $1.09 $1.12 85.40K
03/18/2016 $1.13 $1.18 $1.10 $1.13 142.10K
03/21/2016 $1.13 $1.18 $1.13 $1.17 96.30K
03/22/2016 $1.16 $1.18 $1.13 $1.15 143.10K
Celladon is a clinical-stage biotechnology company focused on the development of cardiovascular gene therapy. Co.'s therapeutic portfolio for diseases characterized by SERCA enzyme deficiency includes gene therapies and small molecule compounds. Co. is evaluating its key product candidate, MYDICAR, in an international Phase 2b trial in patients with heart failure for reduced ejection fraction or HFrEF (also referred to as systolic heart failure), which it refers to as CUPID 2. Co. is also developing MYDICAR for additional indications, such as arteriovenous fistula, or AVF maturation failure, and for the treatment of patients with heart failure who are on a left-ventricular assist device.
CLDN historical stock prices picture
CLDN (CLDN) has the following price history information. Looking back at CLDN historical stock prices for the last five trading days, on March 16, 2016, CLDN opened at $1.12, traded as high as $1.13 and as low as $1.10, and closed at $1.13. Trading volume was a total of 40.60K shares. On March 17, 2016, CLDN opened at $1.12, traded as high as $1.14 and as low as $1.09, and closed at $1.12. Trading volume was a total of 85.40K shares. On March 18, 2016, CLDN opened at $1.13, traded as high as $1.18 and as low as $1.10, and closed at $1.13. Trading volume was a total of 142.10K shares. On March 21, 2016, CLDN opened at $1.13, traded as high as $1.18 and as low as $1.13, and closed at $1.17. Trading volume was a total of 96.30K shares. On March 22, 2016, CLDN opened at $1.16, traded as high as $1.18 and as low as $1.13, and closed at $1.15. Trading volume was a total of 143.10K shares.

CLDN Historical Stock Prices By Date:

CLDN historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into CLDN shares, starting with a $10,000 purchase of CLDN, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 01/31/2014
End date: 03/22/2016
Start price/share: $8.47
End price/share: $1.15
Dividends collected/share: $0.00
Total return: -86.42%
Average Annual Total Return: -60.72%
Starting investment: $10,000.00
Ending investment: $1,357.53
Years: 2.14
Date Close
03/16/2016$1.13
03/17/2016$1.12
03/18/2016$1.13
03/21/2016$1.17
03/22/2016$1.15
CLDN is categorized under the Healthcare sector; below are some other companies in the same sector:

CLDX Historical Stock Prices
CLNN Historical Stock Prices
CLOV Historical Stock Prices
CLPT Historical Stock Prices
CLRB Historical Stock Prices
CLRBW Historical Stock Prices
CLSD Historical Stock Prices
CLSN Historical Stock Prices
CLVS Historical Stock Prices
CLXT Historical Stock Prices

Email EnvelopeFree CLDN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

CLDN Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.